Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Tak

Showing results (161-170 of 203) with videos related to

Pageof 21
Sort By:
Arthritis and Rheumatism|March 6, 2012
Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: results of a forty-eight–week randomized, double-blind, placebo-controlled, parallel-group phase III trialP P Tak, P J Mease, M C Genovese, et al.
Arthritis and Rheumatism|October 1, 1995
Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritisP P Tak, P A van der Lubbe, A Cauli, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 4, 2007
[TNF-blocking drugs and infection; recommendations for daily practice]J W G Jacobs, M C W Creemers, M A van Agtmael, et al.
Clinical Immunology and Immunopathology|August 1, 1996
Expression of the activation antigen CD27 in rheumatoid arthritisP P Tak, R Q Hintzen, J J Teunissen, et al.
Human Gene Therapy|May 6, 2005
Adeno-associated virus pseudotype 5 vector improves gene transfer in arthritic jointsF Apparailly, M Khoury, M J B Vervoordeldonk, et al.
Clinical Immunology and Immunopathology|October 1, 1994
Expression of granzymes A and B in synovial tissue from patients with rheumatoid arthritis and osteoarthritisJ A Kummer, P P Tak, B M Brinkman, et al.
Annals of the Rheumatic Diseases|July 16, 2008
Exposure to nuclear antigens contributes to the induction of humoral autoimmunity during tumour necrosis factor alpha blockadeT Cantaert, L De Rycke, C P Mavragani, et al.
Annals of the Rheumatic Diseases|February 14, 2004
Activation of the STAT1 pathway in rheumatoid arthritisP V Kasperkovitz, N L Verbeet, T J Smeets, et al.
Genes and Immunity|June 18, 2010
Pharmacogenomics of infliximab treatment using peripheral blood cells of patients with rheumatoid arthritisL G M van Baarsen, C A Wijbrandts, D M Gerlag, et al.
Arthritis and Rheumatism|August 1, 2009
Anti-adalimumab antibodies in rheumatoid arthritis patients are associated with interleukin-10 gene polymorphismsG M Bartelds, C A Wijbrandts, M T Nurmohamed, et al.
Pageof 21

Showing results (161-170 of 203) with videos related to

Sort By:
Pageof 21
Arthritis and Rheumatism|March 6, 2012
Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: results of a forty-eight–week randomized, double-blind, placebo-controlled, parallel-group phase III trialP P Tak, P J Mease, M C Genovese, et al.
Arthritis and Rheumatism|October 1, 1995
Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritisP P Tak, P A van der Lubbe, A Cauli, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 4, 2007
[TNF-blocking drugs and infection; recommendations for daily practice]J W G Jacobs, M C W Creemers, M A van Agtmael, et al.
Clinical Immunology and Immunopathology|August 1, 1996
Expression of the activation antigen CD27 in rheumatoid arthritisP P Tak, R Q Hintzen, J J Teunissen, et al.
Human Gene Therapy|May 6, 2005
Adeno-associated virus pseudotype 5 vector improves gene transfer in arthritic jointsF Apparailly, M Khoury, M J B Vervoordeldonk, et al.
Clinical Immunology and Immunopathology|October 1, 1994
Expression of granzymes A and B in synovial tissue from patients with rheumatoid arthritis and osteoarthritisJ A Kummer, P P Tak, B M Brinkman, et al.
Annals of the Rheumatic Diseases|July 16, 2008
Exposure to nuclear antigens contributes to the induction of humoral autoimmunity during tumour necrosis factor alpha blockadeT Cantaert, L De Rycke, C P Mavragani, et al.
Annals of the Rheumatic Diseases|February 14, 2004
Activation of the STAT1 pathway in rheumatoid arthritisP V Kasperkovitz, N L Verbeet, T J Smeets, et al.
Genes and Immunity|June 18, 2010
Pharmacogenomics of infliximab treatment using peripheral blood cells of patients with rheumatoid arthritisL G M van Baarsen, C A Wijbrandts, D M Gerlag, et al.
Arthritis and Rheumatism|August 1, 2009
Anti-adalimumab antibodies in rheumatoid arthritis patients are associated with interleukin-10 gene polymorphismsG M Bartelds, C A Wijbrandts, M T Nurmohamed, et al.
Pageof 21